Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001140361-23-012421
Filing Date
2023-03-20
Accepted
2023-03-20 07:50:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 POS AM ny20008238x1_posam.htm POS AM 324869
2 EXHIBIT 23.1 ny20008238x1_ex23-1.htm EX-23.1 2252
3 EXHIBIT 23.2 ny20008238x1_ex23-2.htm EX-23.2 2829
  Complete submission text file 0001140361-23-012421.txt   331252
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-264585 | Film No.: 23744953
SIC: 2834 Pharmaceutical Preparations